{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:06:26Z","timestamp":1792796786717,"version":"4.5.0"},"reference-count":249,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.phrs.2023.106764","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T11:30:08Z","timestamp":1681126208000},"page":"106764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Nicotinic acetylcholine receptors in neurological and psychiatric diseases"],"prefix":"10.1016","volume":"191","author":[{"suffix":"Jr.","given":"Alvin V.","family":"Terry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2023.106764_bib1","article-title":"Nicotinic Receptors in Brain Diseases","volume":"vol 1","author":"Stitzel","year":"2011"},{"issue":"14","key":"10.1016\/j.phrs.2023.106764_bib2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0024-3205(80)90224-6","article-title":"Stereospecific 3H-nicotine binding to intact and solubilized rat brain membranes and evidence for its noncholinergic nature","volume":"27","author":"Abood","year":"1980","journal-title":"Life Sci."},{"issue":"4470","key":"10.1016\/j.phrs.2023.106764_bib3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1126\/science.7433991","article-title":"Stereospecific nicotine receptors on rat brain membranes","volume":"210","author":"Romano","year":"1980","journal-title":"Sci. (N.Y., N.Y.)"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10799898109038794","article-title":"Noncholinergic, saturable binding of (+\/-)-[3H]nicotine to mouse brain","volume":"2","author":"Sershen","year":"1981","journal-title":"J. Recept. Res."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0026-895X(25)15183-3","article-title":"Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate","volume":"22","author":"Marks","year":"1982","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0026-895X(25)15102-X","article-title":"Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain","volume":"22","author":"Schwartz","year":"1982","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2023.106764_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0024-3205(79)90335-7","article-title":"alpha-Bungarotoxin binding sites in the CNS","volume":"24","author":"Morley","year":"1979","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(81)90239-6","article-title":"Alpha-bungarotoxin binding and central nervous system nicotinic acetylcholine receptors","volume":"6","author":"Oswald","year":"1981","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2023.106764_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.pharmtox.40.1.431","article-title":"Nicotinic receptors at the amino acid level","volume":"40","author":"Corringer","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2023.106764_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10254-003-0005-1","article-title":"Nicotinic acetylcholine receptors: from structure to brain function","volume":"147","author":"Hogg","year":"2003","journal-title":"Rev. Physiol., Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2023.106764_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","article-title":"Neuronal nicotinic receptors: from structure to pathology","volume":"74","author":"Gotti","year":"2004","journal-title":"Prog. Neurobiol."},{"issue":"6315","key":"10.1016\/j.phrs.2023.106764_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/350235a0","article-title":"Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor","volume":"350","author":"Cooper","year":"1991","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0959-4388(93)90121-E","article-title":"Structure of nicotinic acetylcholine receptors","volume":"3","author":"Karlin","year":"1993","journal-title":"Curr. Opin. Neurobiol."},{"issue":"7625","key":"10.1016\/j.phrs.2023.106764_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature19785","article-title":"X-ray structure of the human \u03b14\u03b22 nicotinic receptor","volume":"538","author":"Morales-Perez","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib15","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bcp.2007.07.032","article-title":"The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum","volume":"74","author":"Grady","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"Pt B","key":"10.1016\/j.phrs.2023.106764_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuropharm.2015.01.022","article-title":"Inside-out neuropharmacology of nicotinic drugs","volume":"96","author":"Henderson","year":"2015","journal-title":"Neuropharmacology"},{"issue":"5231","key":"10.1016\/j.phrs.2023.106764_bib17","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1126\/science.7569895","article-title":"Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors","volume":"269","author":"McGehee","year":"1995","journal-title":"Sci. (N. Y., N. Y. )"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106764_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1385\/JMN:30:1:181","article-title":"CNS localization of neuronal nicotinic receptors","volume":"30","author":"Nashmi","year":"2006","journal-title":"J. Mol. Neurosci.: MN"},{"key":"10.1016\/j.phrs.2023.106764_bib19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bcp.2017.12.008","article-title":"The wonderland of neuronal nicotinic acetylcholine receptors","volume":"151","author":"Bertrand","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2023.106764_bib20","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1113\/JP275101","article-title":"Molecular function of \u03b17 nicotinic receptors as drug targets","volume":"596","author":"Bouzat","year":"2018","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tips.2018.01.002","article-title":"Beyond the channel: metabotropic signaling by nicotinic receptors","volume":"39","author":"Kabbani","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"15","key":"10.1016\/j.phrs.2023.106764_bib22","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1021\/jm040219e","article-title":"Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations","volume":"48","author":"Jensen","year":"2005","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1471-4159.1986.tb00753.x","article-title":"Biochemical characterization of alpha-adrenergic receptors in human brain and changes in Alzheimer-type dementia","volume":"47","author":"Shimohama","year":"1986","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0306-4522(00)00071-3","article-title":"Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication","volume":"98","author":"Court","year":"2000","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Paterson","year":"2000","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X","article-title":"Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain","volume":"387","author":"Breese","year":"1997","journal-title":"J. Comp. Neurol."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2023.106764_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0163-7258(01)00161-9","article-title":"Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications","volume":"92","author":"Picciotto","year":"2001","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1568026043451393","article-title":"Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity","volume":"4","author":"Sher","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib30","first-page":"9","article-title":"Generation of epilepsy animal model bearing a genetic abnormality identified in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) of humans","volume":"30","author":"Okada","year":"2010","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2023.106764_bib31","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.2967\/jnumed.121.263198","article-title":"PET imaging of cholinergic neurotransmission in neurodegenerative disorders","volume":"63","author":"Tiepolt","year":"2022","journal-title":"J. Nucl. Med.: Off. Publ., Soc. Nucl. Med."},{"key":"10.1016\/j.phrs.2023.106764_bib32","unstructured":"Alzheimer's disease facts and figures. Alzheimer's Disease and Dementia. (n.d.). Retrieved December 8, 2022, from https:\/\/www.alz.org\/alzheimers-dementia\/facts-figures."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0304-3940(88)90503-4","article-title":"Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains","volume":"86","author":"Nordberg","year":"1988","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib34","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1212\/WNL.38.5.720","article-title":"Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study","volume":"38","author":"Whitehouse","year":"1988","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4522(94)00410-7","article-title":"Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology","volume":"64","author":"Perry","year":"1995","journal-title":"Neuroscience"},{"issue":"17","key":"10.1016\/j.phrs.2023.106764_bib36","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1097\/00001756-199511270-00033","article-title":"Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains","volume":"6","author":"Warpman","year":"1995","journal-title":"Neuroreport"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106764_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0169-328X(99)00030-3","article-title":"Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain","volume":"66","author":"Hellstr\u00f6m-Lindahl","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib38","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1471-4159.2000.0721161.x","article-title":"Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670\/671 mutation","volume":"72","author":"Marutle","year":"1999","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib39","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1999.0731635.x","article-title":"Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease","volume":"73","author":"Martin-Ruiz","year":"1999","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0169-328X(00)00031-0","article-title":"Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients","volume":"76","author":"Burghaus","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1471-4159.2000.0740237.x","article-title":"Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease","volume":"74","author":"Guan","year":"2000","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106764_bib42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-4328(00)00215-1","article-title":"Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches","volume":"113","author":"Wevers","year":"2000","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00002093-199505000-00006","article-title":"Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography","volume":"9","author":"Nordberg","year":"1995","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2023.106764_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0014-2999(00)00064-9","article-title":"Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases","volume":"393","author":"Perry","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-006-0447-7","article-title":"PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease","volume":"188","author":"Kadir","year":"2006","journal-title":"Psychopharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2023.106764_bib46","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1007\/s00259-007-0701-1","article-title":"Acetylcholine receptors in dementia and mild cognitive impairment","volume":"35","author":"Sabri","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib47","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/emboj\/18.5.1235","article-title":"Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors","volume":"18","author":"Zoli","year":"1999","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/jnnp.2006.108209","article-title":"Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I\u20135IA-85380 single-photon-emission computed tomography","volume":"78","author":"O'Brien","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib49","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00259-010-1644-5","article-title":"Decreased cerebral \u03b14\u03b22* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography","volume":"38","author":"Kendziorra","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"Pt 10","key":"10.1016\/j.phrs.2023.106764_bib50","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1093\/brain\/awt195","article-title":"Alterations in \u03b14\u03b22 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology","volume":"136","author":"Okada","year":"2013","journal-title":"Brain: a J. Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib51","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jagp.2016.11.011","article-title":"Cholinergic receptor binding in Alzheimer disease and healthy aging: assessment in vivo with positron emission tomography imaging","volume":"25","author":"Sultzer","year":"2017","journal-title":"Am. J. Geriatr. Psychiatry: Off. J. Am. Assoc. Geriatr. Psychiatry"},{"issue":"6","key":"10.1016\/j.phrs.2023.106764_bib52","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/brain\/awy099","article-title":"Cognitive correlates of \u03b14\u03b22 nicotinic acetylcholine receptors in mild Alzheimer's dementia","volume":"141","author":"Sabri","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2023.106764_bib53","first-page":"211","article-title":"Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's disease","volume":"61","author":"Engidawork","year":"2001","journal-title":"J. Neural Transm. Suppl."},{"issue":"7","key":"10.1016\/j.phrs.2023.106764_bib54","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1046\/j.1460-9568.1999.00676.x","article-title":"Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein","volume":"11","author":"Wevers","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/138161206775474486","article-title":"Brain neuronal nicotinic receptors as new targets for drug discovery","volume":"12","author":"Gotti","year":"2006","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"10.1016\/j.phrs.2023.106764_bib56","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/archneur.64.12.1771","article-title":"Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease","volume":"64","author":"Counts","year":"2007","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/glia.10132","article-title":"Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes","volume":"41","author":"Teaktong","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2023.106764_bib58","article-title":"Brain imaging of nicotinic receptors in Alzheimer's disease","volume":"2010","author":"Wu","year":"2010","journal-title":"Int. J. Alzheimer'S. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib59","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archneurol.2009.46","article-title":"Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease","volume":"66","author":"Ikonomovic","year":"2009","journal-title":"Arch. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106764_bib60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1385\/JMN:30:1:83","article-title":"Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes","volume":"30","author":"Jones","year":"2006","journal-title":"J. Mol. Neurosci.: MN"},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib61","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3233\/JAD-170591","article-title":"In vivo Depiction of \u03b17 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease","volume":"61","author":"Nakaizumi","year":"2018","journal-title":"J. Alzheimer'S. Dis.: JAD"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib62","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2967\/jnumed.119.230979","article-title":"High Availability of the \u03b17-nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment: a pilot study using 18F-ASEM PET","volume":"61","author":"Coughlin","year":"2020","journal-title":"J. Nucl. Med"},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib63","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/138945012800398973","article-title":"\u03b17 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?","volume":"13","author":"Hernandez","year":"2012","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib64","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1046\/j.1471-4159.2000.0751155.x","article-title":"Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors","volume":"75","author":"Wang","year":"2000","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib65","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bcp.2011.06.039","article-title":"Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease","volume":"82","author":"Parri","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"25","key":"10.1016\/j.phrs.2023.106764_bib66","doi-asserted-by":"crossref","first-page":"22768","DOI":"10.1074\/jbc.M200164200","article-title":"Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins","volume":"277","author":"Dineley","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/jpet.104.070417","article-title":"Electrophysiological, pharmacological, and molecular evidence for alpha7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons","volume":"311","author":"Wu","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib68","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1523\/JNEUROSCI.3952-08.2009","article-title":"A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides","volume":"29","author":"Liu","year":"2009","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2023.106764_bib69","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2202-13-155","article-title":"Functional \u03b17\u03b22 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid \u03b2 peptides","volume":"13","author":"Liu","year":"2012","journal-title":"BMC Neurosci."},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib70","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.bcp.2011.06.018","article-title":"The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of \u03b17*nAChR function","volume":"82","author":"Araud","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"27","key":"10.1016\/j.phrs.2023.106764_bib71","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.1074\/jbc.RA117.001698","article-title":"A human-specific, truncated \u03b17 nicotinic receptor subunit assembles with full-length \u03b17 and forms functional receptors with different stoichiometries","volume":"293","author":"Lasala","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106764_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.143996","article-title":"Global proteomic profiling of the uniquely human CHRFAM7A gene in transgenic mouse brain","volume":"714","author":"Jiang","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.phrs.2023.106764_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102892","article-title":"CHRFAM7A: A human specific fusion gene, accounts for the translational gap for cholinergic strategies in Alzheimer's disease","volume":"59","author":"Szigeti","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2023.106764_bib74","unstructured":"World Health Organization. (n.d.). Parkinson disease. World Health Organization. Retrieved December 8, 2022, from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/parkinson-disease."},{"issue":"6","key":"10.1016\/j.phrs.2023.106764_bib75","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann. Neurol."},{"issue":"9996","key":"10.1016\/j.phrs.2023.106764_bib76","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet (Lond., Engl. )"},{"issue":"12","key":"10.1016\/j.phrs.2023.106764_bib77","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib78","first-page":"912","article-title":"Exploring causality of the association between smoking and Parkinson's disease","volume":"48","author":"Gallo","year":"2019","journal-title":"Int J. Epidemiol. 2019 Jun. 1"},{"issue":"20","key":"10.1016\/j.phrs.2023.106764_bib79","doi-asserted-by":"crossref","first-page":"e2132","DOI":"10.1212\/WNL.0000000000009437","article-title":"Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors","volume":"94","author":"Mappin-Kasirer","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02257646","article-title":"Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types","volume":"2","author":"Perry","year":"1990","journal-title":"J. Neural Transm. Park. 'S. Dis. Dement. Sect."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib81","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(91)90588-M","article-title":"A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease","volume":"547","author":"Rinne","year":"1991","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib82","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1471-4159.1992.tb09752.x","article-title":"Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases","volume":"58","author":"Aubert","year":"1992","journal-title":"J. Neurochem."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2023.106764_bib83","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2999(92)90843-S","article-title":"Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain","volume":"217","author":"Aubert","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib84","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0306-4522(98)00465-5","article-title":"Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine","volume":"90","author":"Piggott","year":"1999","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib85","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/mol.57.3.642","article-title":"5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors","volume":"57","author":"Mukhin","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib86","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.npp.1300302","article-title":"Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380","volume":"29","author":"Pimlott","year":"2004","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib87","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00401-006-0114-4","article-title":"Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease","volume":"112","author":"Fujita","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106764_bib88","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2007.02.014","article-title":"Quantification of nicotinic acetylcholine receptors in Parkinson's disease with (123)I-5IA SPECT","volume":"256","author":"Oishi","year":"2007","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2023.106764_bib89","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jcbfm.2009.74","article-title":"Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease","volume":"29","author":"Kas","year":"2009","journal-title":"J. Cereb. Blood Flow. Metab.: Off. J. Int. Soc. Cereb. Blood Flow. Metab."},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib90","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/archgenpsychiatry.2009.106","article-title":"Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease","volume":"66","author":"Meyer","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib91","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/ane.12259","article-title":"Nicotinic \u03b14\u03b22 acetylcholine receptors and cognitive function in Parkinson's disease","volume":"130","author":"Lorenz","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.phrs.2023.106764_bib92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fnagi.2014.00213","article-title":"Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease","volume":"6","author":"Isaias","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib93","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/jpet.102.039347","article-title":"Declines in different beta2* nicotinic receptor populations in monkey striatum after nigrostriatal damage","volume":"303","author":"Kulak","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/mol.104.006015","article-title":"Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA","volume":"67","author":"Quik","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib95","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1124\/mol.107.035998","article-title":"Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson's disease striatum","volume":"72","author":"Bordia","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib96","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1471-4159.2004.02177.x","article-title":"Loss of alpha-conotoxinMII- and A85380-sensitive nicotinic receptors in Parkinson's disease striatum","volume":"88","author":"Quik","year":"2004","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib97","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/mol.63.5.1169","article-title":"Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice","volume":"63","author":"Quik","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib98","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.expneurol.2004.10.004","article-title":"Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus","volume":"191","author":"Bohr","year":"2005","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib99","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0006-8993(02)03571-0","article-title":"Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease","volume":"956","author":"Guan","year":"2002","journal-title":"Brain Res."},{"issue":"20","key":"10.1016\/j.phrs.2023.106764_bib100","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"6 Pt B","key":"10.1016\/j.phrs.2023.106764_bib101","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1006\/nbdi.2000.0317","article-title":"Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease--a stereological approach","volume":"7","author":"Banerjee","year":"2000","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib102","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1353-8020(03)00028-2","article-title":"Loss of nicotinic acetylcholine receptor subunits alpha4 and alpha7 in the cerebral cortex of Parkinson patients","volume":"9","author":"Burghaus","year":"2003","journal-title":"Park. Relat. Disord."},{"issue":"10","key":"10.1016\/j.phrs.2023.106764_bib103","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1528-1167.2006.00633.x","article-title":"Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization","volume":"47","author":"Theodore","year":"2006","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib104","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yebeh.2008.10.013","article-title":"Comorbidity, health screening, and quality of life among persons with a history of epilepsy","volume":"14","author":"Elliott","year":"2009","journal-title":"Epilepsy Behav.: EB"},{"key":"10.1016\/j.phrs.2023.106764_bib105","unstructured":"Fahey, H., Pastor, J., Laliberte, R., Mackay, K., Oravec, A., Poulos, H., Costello, J., & Wyckoff, K.A. (2020). Examining the Economic Impact and Implications of Epilepsy."},{"key":"10.1016\/j.phrs.2023.106764_bib106","article-title":"Epilepsy as a disease affecting neural networks: a neurophysiological perspective","author":"San-Juan","year":"2022","journal-title":"Neurol. (Engl. Ed. )"},{"key":"10.1016\/j.phrs.2023.106764_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.674483","article-title":"The pharmacoresistant epilepsy: an overview on existant and new emerging therapies","volume":"12","author":"Fattorusso","year":"2021","journal-title":"Front Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib108","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng1095-201","article-title":"A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy","volume":"11","author":"Steinlein","year":"1995","journal-title":"Nat. Genet"},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152984","article-title":"Association of common polymorphisms in the nicotinic acetylcholine receptor alpha4 subunit gene with an electrophysiological endophenotype in a large population-based sample","volume":"11","author":"Mobascher","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00424-009-0766-8","article-title":"Nicotinic receptor channelopathies and epilepsy","volume":"460","author":"Steinlein","year":"2010","journal-title":"Pflug. Arch."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib111","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1124\/mol.107.044545","article-title":"Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore","volume":"74","author":"Hoda","year":"2008","journal-title":"Mol. Pharm."},{"issue":"20","key":"10.1016\/j.phrs.2023.106764_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012124","article-title":"Genetic variant in nicotinic receptor alpha4-subunit causes sleep-related hyperkinetic epilepsy via increased channel opening","volume":"23","author":"Mazzaferro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib113","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/506459","article-title":"Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear","volume":"79","author":"Aridon","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.sleep.2007.11.010","article-title":"CHRNA2 mutations are rare in the NFLE population: evaluation of a large cohort of Italian patients","volume":"10","author":"Combi","year":"2009","journal-title":"Sleep. Med."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2007.06.006","article-title":"A major role of the nicotinic acetylcholine receptor gene CHRNA2 in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is unlikely","volume":"422","author":"Gu","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.phrs.2023.106764_bib116","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.febslet.2009.04.024","article-title":"Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene","volume":"583","author":"Hoda","year":"2009","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib117","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1111\/epi.12967","article-title":"Mutation of CHRNA2 in a family with benign familial infantile seizures: Potential role of nicotinic acetylcholine receptor in various phenotypes of epilepsy","volume":"56","author":"Trivisano","year":"2015","journal-title":"Epilepsia"},{"issue":"15","key":"10.1016\/j.phrs.2023.106764_bib118","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1212\/WNL.0000000000001471","article-title":"Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function","volume":"84","author":"Conti","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib119","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1212\/WNL.53.8.1749","article-title":"A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy","volume":"53","author":"Hirose","year":"1999","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib120","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/archneur.56.8.1004","article-title":"Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene","volume":"56","author":"Saenz","year":"1999","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib121","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1528-1157.2003.07603.x","article-title":"Evidence for S284L mutation of the CHRNA4 in a white family with autosomal dominant nocturnal frontal lobe epilepsy","volume":"44","author":"Rozycka","year":"2003","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2022.104444","article-title":"Autosomal dominant sleep-related hypermotor epilepsy caused by a previously unreported CHRNA4 variant","volume":"65","author":"Nielsen","year":"2022","journal-title":"Eur. J. Med Genet"},{"issue":"7","key":"10.1016\/j.phrs.2023.106764_bib123","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1528-1157.2003.61102.x","article-title":"A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy","volume":"44","author":"Leniger","year":"2003","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib124","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/sleep\/22.5.637","article-title":"SER252PHE and 776INS3 mutations in the CHRNA4 gene are rare in the Italian ADNFLE population","volume":"22","author":"Tenchini","year":"1999","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/316946","article-title":"CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy","volume":"68","author":"Phillips","year":"2001","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.phrs.2023.106764_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102279","article-title":"The beta2(V287L) nicotinic subunit linked to sleep-related epilepsy differently affects fast-spiking and regular spiking somatostatin-expressing neurons in murine prefrontal cortex","volume":"214","author":"Meneghini","year":"2022","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib127","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.nbd.2005.05.013","article-title":"The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits","volume":"20","author":"Bertrand","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106764_bib128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.eplepsyres.2011.03.002","article-title":"The identification of a novel mutation of nicotinic acetylcholine receptor gene CHRNB2 in a Chinese patient: Its possible implication in non-familial nocturnal frontal lobe epilepsy","volume":"95","author":"Liu","year":"2011","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.yebeh.2012.07.027","article-title":"A case of autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) coexisting with pervasive developmental disorder harboring SCN1A mutation in addition to CHRNB2 mutation","volume":"25","author":"Sone","year":"2012","journal-title":"Epilepsy Behav."},{"issue":"15","key":"10.1016\/j.phrs.2023.106764_bib130","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.0b013e3181bc0158","article-title":"Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures","volume":"73","author":"Kurahashi","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib131","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.nbd.2005.05.013","article-title":"The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits","volume":"20","author":"Bertrand","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2023.106764_bib132","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1528-1157.2003.61102.x","article-title":"A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy","volume":"44","author":"Leniger","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2023.106764_bib133","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.phrs.2018.11.031","article-title":"Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry","volume":"139","author":"Indurthi","year":"2019","journal-title":"Pharm. Res"},{"issue":"47","key":"10.1016\/j.phrs.2023.106764_bib134","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1523\/JNEUROSCI.2961-08.2008","article-title":"Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype","volume":"28","author":"Zhu","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2023.106764_bib135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neures.2015.06.003","article-title":"Spontaneous epileptic seizures in transgenic rats harboring a human ADNFLE missense mutation in the beta2-subunit of the nicotinic acetylcholine receptor","volume":"100","author":"Shiba","year":"2015","journal-title":"Neurosci. Res"},{"key":"10.1016\/j.phrs.2023.106764_bib136","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fncir.2014.00087","article-title":"Multi-electrode array study of neuronal cultures expressing nicotinic beta2-V287L subunits, linked to autosomal dominant nocturnal frontal lobe epilepsy. An in vitro model of spontaneous epilepsy","volume":"8","author":"Gullo","year":"2014","journal-title":"Front Neural Circuits"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib137","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.pbb.2012.10.014","article-title":"Mice expressing the ADNFLE valine 287 leucine mutation of the Beta2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function","volume":"103","author":"O'Neill","year":"2013","journal-title":"Pharm. Biochem Behav."},{"issue":"9","key":"10.1016\/j.phrs.2023.106764_bib138","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/bph.14974","article-title":"Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant alpha4 subunit of nicotinic ACh receptor","volume":"177","author":"Fukuyama","year":"2020","journal-title":"Br. J. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2023.106764_bib139","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/ddp004","article-title":"Expression of mutant beta2 nicotinic receptors during development is crucial for epileptogenesis","volume":"18","author":"Manfredi","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/cercor\/bhr390","article-title":"Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors","volume":"23","author":"Poorthuis","year":"2013","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.phrs.2023.106764_bib141","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75829","article-title":"A tonic nicotinic brake controls spike timing in striatal spiny projection neurons","volume":"11","author":"Matityahu","year":"2022","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib142","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0883073820974851","article-title":"Nicotine: a targeted therapy for epilepsy due to nAChR gene variants","volume":"36","author":"Fox","year":"2021","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.phrs.2023.106764_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106792","article-title":"Precision treatment with nicotine in autosomal dominant sleep-related hypermotor epilepsy (ADSHE): An observational study of clinical outcome and serum cotinine levels in 17 patients","volume":"178","author":"Brodtkorb","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.phrs.2023.106764_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106944","article-title":"Remarkable effect of transdermal nicotine in children with CHRNA4-related autosomal dominant sleep-related hypermotor epilepsy","volume":"105","author":"Lossius","year":"2020","journal-title":"Epilepsy Behav."},{"issue":"21","key":"10.1016\/j.phrs.2023.106764_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11216470","article-title":"Diagnosis and management of functional tic-like phenomena","volume":"11","author":"Malaty","year":"2022","journal-title":"J. Clin. Med"},{"issue":"13","key":"10.1016\/j.phrs.2023.106764_bib146","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1080\/14656566.2022.2107902","article-title":"Current and emerging pharmacotherapeutic strategies for Tourette syndrome","volume":"23","author":"Cavanna","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.phrs.2023.106764_bib147","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2012.05.043","article-title":"Pharmacological treatment of tic disorders and tourette syndrome","volume":"68","author":"Roessner","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2023.106764_bib148","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00702-013-0979-z","article-title":"The pharmacology of Tourette syndrome","author":"Thomas","year":"2013","journal-title":"J. Neural Trans."},{"key":"10.1016\/j.phrs.2023.106764_bib149","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/B978-0-12-411546-0.00015-9","article-title":"Emerging treatment strategies in Tourette syndrome: what's in the pipeline?","volume":"112","author":"Termine","year":"2013","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.phrs.2023.106764_bib150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/B978-0-12-411546-0.00004-4","article-title":"Nondopaminergic neurotransmission in the pathophysiology of Tourette syndrome","volume":"112","author":"Udvardi","year":"2013","journal-title":"Int. Rev. Neurobiol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib151","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1073\/pnas.1419533112","article-title":"Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome","volume":"112","author":"Xu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib152","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.biopsych.2014.07.018","article-title":"Transcriptome analysis of the human striatum in tourette syndrome","volume":"79","author":"Lennington","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib153","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ntr\/nty063","article-title":"Potential therapeutic application for nicotinic receptor drugs in movement disorders","volume":"21","author":"Quik","year":"2019","journal-title":"Nicotine Tob. Res.: Off. J. Soc. Res. Nicotine Tob."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib154","first-page":"19","article-title":"Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome","volume":"43","author":"Sanberg","year":"1989","journal-title":"Biomed. Pharm. 1989"},{"issue":"6","key":"10.1016\/j.phrs.2023.106764_bib155","first-page":"793","article-title":"Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder","volume":"148","author":"McConville","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"8936","key":"10.1016\/j.phrs.2023.106764_bib156","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(94)90388-3","article-title":"Longlasting improvement of Tourette's syndrome with transdermal nicotine","volume":"344","author":"Dursun","year":"1994","journal-title":"Lancet (Lond., Engl. )"},{"issue":"12","key":"10.1016\/j.phrs.2023.106764_bib157","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/00004583-199612000-00015","article-title":"Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome","volume":"35","author":"Silver","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"9","key":"10.1016\/j.phrs.2023.106764_bib158","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.v62n0908","article-title":"Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study","volume":"62","author":"Silver","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.phrs.2023.106764_bib159","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3223(00)00945-8","article-title":"Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine)","volume":"48","author":"Shytle","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib160","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.physbeh.2012.06.023","article-title":"Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond","volume":"107","author":"Sanberg","year":"2012","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib161","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/cap.2000.10.59","article-title":"Mecamylamine in Tourette's syndrome: a two-year retrospective case study","volume":"10","author":"Silver","year":"2000","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib162","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/WNF.0000000000000244","article-title":"Acute worsening of tics on varenicline","volume":"40","author":"Mittal","year":"2017","journal-title":"Clin. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib163","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/ejn.13949","article-title":"Cholinergic modulation of striatal microcircuits","volume":"49","author":"Abudukeyoumu","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2023.106764_bib164","unstructured":"World Health Organization. (n.d.). Schizophrenia. World Health Organization. Retrieved December 8, 2022, from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schizophrenia."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib165","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0006-3223(00)01027-1","article-title":"Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications","volume":"49","author":"Green","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2023.106764_bib166","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1192\/S0007125000139856","article-title":"Smoking in chronic schizophrenia","volume":"149","author":"Gopalaswamy","year":"1986","journal-title":"Br. J. Psychiatry.: J. Ment. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib167","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00001504-200005000-00015","article-title":"Comorbidity of psychiatric and substance abuse disorders","volume":"13","author":"George","year":"2000","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(96)00302-2","article-title":"Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers","volume":"42","author":"Olincy","year":"1997","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib169","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eurpsy.2004.09.005","article-title":"Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls","volume":"20","author":"Strand","year":"2005","journal-title":"Eur. Psychiatry.: J. Assoc. Eur. Psychiatr."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2023.106764_bib170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1300\/J374v03n03_05","article-title":"Smoking, genetics and Schizophrenia: evidence for self medication","volume":"3","author":"Leonard","year":"2007","journal-title":"J. Dual Diagn."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib171","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/appi.ps.201700118","article-title":"Cigarette smoking by patients with serious mental illness, 1999-2016: an increasing disparity","volume":"69","author":"Dickerson","year":"2018","journal-title":"Psychiatr. Serv. (Wash., D.C.)"},{"issue":"7","key":"10.1016\/j.phrs.2023.106764_bib172","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0269881117705071","article-title":"Targeting neuronal dysfunction in schizophrenia with nicotine: evidence from neurophysiology to neuroimaging","volume":"31","author":"Smucny","year":"2017","journal-title":"J. Psychopharmacol. (Oxf., Engl. )"},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib173","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0893-133X(00)00121-4","article-title":"Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia","volume":"23","author":"Breese","year":"2000","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib174","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1176\/appi.ajp.2011.11020189","article-title":"Lower \u00df2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia","volume":"169","author":"D'Souza","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.phrs.2023.106764_bib175","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biopsych.2013.11.001","article-title":"In vivo evidence for \u03b22 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia","volume":"76","author":"Esterlis","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib176","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00221-006-0458-y","article-title":"Genetic interaction between alpha4 and beta2 subunits of high affinity nicotinic receptor: analysis in schizophrenia","volume":"174","author":"De Luca","year":"2006","journal-title":"Exp. brain Res."},{"issue":"6","key":"10.1016\/j.phrs.2023.106764_bib177","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1139\/jpn.0740","article-title":"Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia","volume":"32","author":"Voineskos","year":"2007","journal-title":"J. Psychiatry Neurosci.: JPN"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib178","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib179","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1097\/00001756-199906030-00028","article-title":"Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain","volume":"10","author":"Guan","year":"1999","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib180","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1471-4159.1999.0731590.x","article-title":"Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus","volume":"73","author":"Court","year":"1999","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.phrs.2023.106764_bib181","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ijnp\/pyy021","article-title":"Imaging of \u03b17-nAChR with [18F]ASEM: reproducibility, occupancy, receptor density, and changes in schizophrenia","volume":"21","author":"Wong","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib182","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2967\/jnumed.119.230979","article-title":"High availability of the \u03b17-nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment: a pilot study using 18F-ASEM PET","volume":"61","author":"Coughlin","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib183","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/1096-8628(20010108)105:1<20::AID-AJMG1047>3.0.CO;2-C","article-title":"Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7)","volume":"105","author":"Freedman","year":"2001","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib184","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajmg.b.20061","article-title":"Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects","volume":"123B","author":"Gault","year":"2003","journal-title":"Am. J. Med. Genet. Part B, Neuropsychiatr. Genet.: Off. Publ. Int. Soc. Psychiatr. Genet."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biopsych.2006.03.054","article-title":"Genetics of chromosome 15q13-q14 in schizophrenia","volume":"60","author":"Leonard","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2023.106764_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.07.041","article-title":"A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia","volume":"1291","author":"Sinkus","year":"2009","journal-title":"Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2023.106764_bib187","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2008.12.017","article-title":"Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia","volume":"109","author":"Stephens","year":"2009","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib188","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11920-003-0032-2","article-title":"The genetics of sensory gating deficits in schizophrenia","volume":"5","author":"Freedman","year":"2003","journal-title":"Curr. Psychiatry Rep."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib189","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00213-003-1750-1","article-title":"Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia","volume":"174","author":"Martin","year":"2004","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib190","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bcp.2007.05.023","article-title":"Heterogeneity and complexity of native brain nicotinic receptors","volume":"74","author":"Gotti","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2023.106764_bib191","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1176\/appi.ajp.2015.14080978","article-title":"CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders","volume":"172","author":"Kunii","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2023.106764_bib192","unstructured":"World Health Organization. (n.d.). Depression. World Health Organization. Retrieved December 8, 2022, from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression."},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib193","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41380-018-0219-x","article-title":"Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics","volume":"24","author":"Dulawa","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib194","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.amepre.2019.12.023","article-title":"Trends in the prevalence of current, daily, and nondaily cigarette smoking and quit ratios by depression status in the U.S.: 2005-2017","volume":"58","author":"Weinberger","year":"2020","journal-title":"Am. J. Prev. Med."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib195","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0091-3057(01)00651-7","article-title":"Neurobiology of the nicotine withdrawal syndrome","volume":"70","author":"Kenny","year":"2001","journal-title":"Pharmacol., Biochem., Behav."},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib196","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1177\/0269881110391831","article-title":"Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline","volume":"25","author":"Andreasen","year":"2011","journal-title":"J. Psychopharmacol. (Oxf., Engl. )"},{"issue":"10","key":"10.1016\/j.phrs.2023.106764_bib197","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/0269881110364271","article-title":"Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test","volume":"25","author":"Andreasen","year":"2011","journal-title":"J. Psychopharmacol. (Oxf., Engl. )"},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib198","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF02246496","article-title":"Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients","volume":"121","author":"Sal\u00edn-Pascual","year":"1995","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib199","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00213-006-0516-y","article-title":"Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial","volume":"189","author":"McClernon","year":"2006","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-010-1932-6","article-title":"Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature","volume":"212","author":"Philip","year":"2010","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib201","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1523\/JNEUROSCI.13-02-00596.1993","article-title":"Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium","volume":"13","author":"S\u00e9gu\u00e9la","year":"1993","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib202","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cne.903490302","article-title":"Immunocytochemical localization of the alpha 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system","volume":"349","author":"Dominguez del Toro","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.phrs.2023.106764_bib203","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/104105","article-title":"The nicotinic acetylcholine receptor as a target for antidepressant drug development","volume":"2012","author":"Philip","year":"2012","journal-title":"Sci. World J."},{"issue":"8","key":"10.1016\/j.phrs.2023.106764_bib204","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1176\/appi.ajp.2012.11101546","article-title":"Persistent \u03b22*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder","volume":"169","author":"Saricicek","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.phrs.2023.106764_bib205","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.biopsych.2013.04.004","article-title":"Changes in the cholinergic system between bipolar depression and euthymia as measured with [123I]5IA single photon emission computed tomography","volume":"74","author":"Hannestad","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.phrs.2023.106764_bib206","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2010.09.004","article-title":"Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis","volume":"31","author":"Mineur","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib207","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-011-2271-y","article-title":"Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380","volume":"217","author":"Caldarone","year":"2011","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.phrs.2023.106764_bib208","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2004.08.010","article-title":"High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation","volume":"56","author":"Caldarone","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib209","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-006-0568-z","article-title":"The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice","volume":"189","author":"Rabenstein","year":"2006","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib210","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/FBP.0b013e32832c713e","article-title":"Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex","volume":"20","author":"Andreasen","year":"2009","journal-title":"Behav. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2023.106764_bib211","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/0269881108091587","article-title":"Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests","volume":"23","author":"Andreasen","year":"2009","journal-title":"J. Psychopharmacol. (Oxf., Engl. )"},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib212","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1124\/mol.106.027318","article-title":"Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them","volume":"70","author":"Xiao","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib213","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","article-title":"It is not \"either\/or\": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood","volume":"84","author":"Picciotto","year":"2008","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib214","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/jpet.108.145292","article-title":"Desensitization of nicotinic acetylcholine receptors as a strategy for drug development","volume":"328","author":"Buccafusco","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2023.106764_bib215","unstructured":"U.S. Department of Health and Human Services. (n.d.). Any anxiety disorder. National Institute of Mental Health. Retrieved December 8, 2022, from https:\/\/www.nimh.nih.gov\/health\/statistics\/any-anxiety-disorder."},{"key":"10.1016\/j.phrs.2023.106764_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108411","article-title":"Molecular and neuronal mechanisms underlying the effects of adolescent nicotine exposure on anxiety and mood disorders","volume":"184","author":"Laviolette","year":"2021","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.phrs.2023.106764_bib217","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1360-0443.1992.tb03121.x","article-title":"Increased desire to smoke during acute stress","volume":"87","author":"Perkins","year":"1992","journal-title":"Br. J. Addict."},{"issue":"10","key":"10.1016\/j.phrs.2023.106764_bib218","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/ntr\/ntp120","article-title":"Self-perceived smoking motives and their correlates in a general population sample","volume":"11","author":"Fidler","year":"2009","journal-title":"Nicotine Tob. Res.: Off. J. Soc. Res. Nicotine Tob."},{"issue":"6","key":"10.1016\/j.phrs.2023.106764_bib219","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0306-4603(97)00063-4","article-title":"Individual differences in the context of smoking lapse episodes","volume":"22","author":"Shiffman","year":"1997","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5993\/AJHB.25.2.7","article-title":"Predicting regular cigarette use among continuation high school students","volume":"25","author":"Skara","year":"2001","journal-title":"Am. J. Health Behav."},{"key":"10.1016\/j.phrs.2023.106764_bib221","unstructured":"Andreasen, J.T. (2022). [Tobacco dependence, anxiety, and depression]. Ugeskr Laeger, 184(14)."},{"issue":"11","key":"10.1016\/j.phrs.2023.106764_bib222","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1111\/bph.13090","article-title":"Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at \u03b22*nicotinic acetylcholine receptors","volume":"172","author":"Anderson","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2023.106764_bib223","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1037\/0003-066X.54.10.817","article-title":"Does cigarette smoking cause stress?","volume":"54","author":"Parrott","year":"1999","journal-title":"Am. Psychol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib224","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ntt.2009.12.009","article-title":"Late emerging effects of prenatal and early postnatal nicotine exposure on the cholinergic system and anxiety-like behavior","volume":"32","author":"Eppolito","year":"2010","journal-title":"Neurotoxicology Teratol."},{"issue":"16","key":"10.1016\/j.phrs.2023.106764_bib225","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.neuron.2021.06.013","article-title":"Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety","volume":"109","author":"Nguyen","year":"2021","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib226","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/npp.2009.83","article-title":"The neurocircuitry of fear, stress, and anxiety disorders","volume":"35","author":"Shin","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"34","key":"10.1016\/j.phrs.2023.106764_bib227","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1523\/JNEUROSCI.5835-12.2013","article-title":"Prenatal exposure to nicotine stimulates neurogenesis of orexigenic peptide-expressing neurons in hypothalamus and amygdala","volume":"33","author":"Chang","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2023.106764_bib228","article-title":"The effect of acute nicotine administration on human delay cued and context fear conditioning","author":"Palmisano","year":"2022","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.phrs.2023.106764_bib229","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2018.03.002","article-title":"Nicotine exposure leads to deficits in differential cued fear conditioning in mice and humans: A potential role of the anterior cingulate cortex","volume":"673","author":"Kutlu","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152984","article-title":"Association of common polymorphisms in the nicotinic acetylcholine receptor alpha4 subunit gene with an electrophysiological endophenotype in a large population-based sample","volume":"11","author":"Mobascher","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2023.106764_bib231","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2014.11.047","article-title":"High-throughput analysis of behavior for drug discovery","volume":"750","author":"Alexandrov","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106764_bib232","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.668065","article-title":"Differentiating the neuropharmacological properties of nicotinic acetylcholine receptor-activating alkaloids","volume":"13","author":"Alijevic","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib233","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.physbeh.2006.08.026","article-title":"Anxiolytic effects of nicotine in zebrafish","volume":"90","author":"Levin","year":"2007","journal-title":"Physiol. Behav."},{"issue":"6","key":"10.1016\/j.phrs.2023.106764_bib234","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1037\/0735-7044.112.6.1423","article-title":"Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus","volume":"112","author":"File","year":"1998","journal-title":"Behav. Neurosci."},{"issue":"30","key":"10.1016\/j.phrs.2023.106764_bib235","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1523\/JNEUROSCI.0937-11.2011","article-title":"\u03b14\u03b22 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief","volume":"31","author":"McGranahan","year":"2011","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2023.106764_bib236","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048665","article-title":"Low dose nicotine and antagonism of \u03b22 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice","volume":"7","author":"Anderson","year":"2012","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib237","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.neuropharm.2012.06.006","article-title":"Acute behavioural responses to nicotine and nicotine withdrawal syndrome are modified in GABA(B1) knockout mice","volume":"63","author":"Varani","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib238","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s002130050976","article-title":"Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine","volume":"144","author":"Ouagazzal","year":"1999","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.phrs.2023.106764_bib239","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/sj.bjp.0703991","article-title":"Social isolation modifies nicotine's effects in animal tests of anxiety","volume":"132","author":"Cheeta","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106764_bib240","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s002130100681","article-title":"The dorsal raph\u00e9 nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses","volume":"155","author":"Cheeta","year":"2001","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib241","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000161129","article-title":"Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats","volume":"82","author":"Zarrindast","year":"2008","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2023.106764_bib242","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.110.166280","article-title":"Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior","volume":"334","author":"Turner","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib243","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neuropharm.2007.01.006","article-title":"Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL\/6J mice","volume":"52","author":"Mineur","year":"2007","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.phrs.2023.106764_bib244","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1073\/pnas.041582598","article-title":"Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety","volume":"98","author":"Labarca","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.phrs.2023.106764_bib245","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bcp.2015.07.027","article-title":"Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders","volume":"97","author":"Terry","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib246","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/ntr\/nty166","article-title":"Nicotinic acetylcholine receptor ligands, cognitive function, and preclinical approaches to drug discovery","volume":"21","author":"Terry","year":"2019","journal-title":"Nicotine Tob. Res.: Off. J. Soc. Res. Nicotine Tob."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib247","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/ntr\/nty116","article-title":"Nicotinic acetylcholine receptor agonists for the treatment of Alzheimer's dementia: an update","volume":"21","author":"Hoskin","year":"2019","journal-title":"Nicotine Tob. Res.: Off. J. Soc. Res. Nicotine Tob."},{"issue":"3","key":"10.1016\/j.phrs.2023.106764_bib248","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ntr\/nty034","article-title":"Alpha7 nicotinic receptors as therapeutic targets in schizophrenia","volume":"21","author":"Tregellas","year":"2019","journal-title":"Nicotine Tob. Res.: Off. J. Soc. Res. Nicotine Tob."},{"key":"10.1016\/j.phrs.2023.106764_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108053","article-title":"\u03b17 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: update on animal and clinical studies and strategies for the future","volume":"170","author":"Terry","year":"2020","journal-title":"Neuropharmacology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:42:40Z","timestamp":1760913760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":249,"alternative-id":["S1043661823001202"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106764","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinic acetylcholine receptors in neurological and psychiatric diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106764"}}